A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents

Badesha, Arshpreet Singh; Bains, Prab Rajan Singh; Bains, Bal Rajan Singh; Khan, Taha

doi:10.1016/j.jvsv.2021.04.014

Cited by 21 publications

(12 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent meta-analysis of 16 single-arm observational studies of endovenous stenting included 1,688 patients, 70.5% with PTS and the rest with NIVLs. 36 The reported primary patency ranged from 59% to 94%, and secondary patency ranged from 87% to 100%. 36 Encouraging data are also emerging for the long-term patency rate of endovenous stenting of CVOO.…”

Section: Next Step: Endovenous Interventionmentioning

confidence: 99%

See 1 more Smart Citation

Chronic venous outflow obstruction: An important cause of chronic venous disease

Harris

Lim

2021

CCJM

View full text Add to dashboard Cite

R ecent advances in imaging and stent technology are changing the management of chronic venous outfl ow obstruction (CVOO), an important cause of chronic venous disease (CVD). Evidence increasingly supports endovascular intervention as a potentially effective and safe treatment option.This article reviews the key factors to consider in management of CVOO and advises on how best to get patients the care they need. ■ CHALLENGES: QUALITY OF LIFE, TREATMENT OPTIONSCVOO negatively affects quality of life and mental health. The presentation of CVOO can be similar to that of superfi cial venous incompetence, but proximal edema tends to be more signifi cant in CVOO. Common manifestations include leg-swelling and pain, limited mobility, chronic ulceration, and venous claudication. Neglen 1 and Raju 2 estimated that such lesions occurred in up to 55% of patients with signifi cant CVD, especially in those with postthrombotic syndrome (PTS). Recent reports suggest that CVOO may also contribute to chronic pelvic pain, including pelvic congestion syndrome, 3 although this observation remains controversial and requires further study.Consequently, patients are subjected to long-term pain and discomfort, the need for chronic leg ulcer management, and reduced physical activity. 4 Healthcare systems therefore allocate signifi cant resources for the treatment of CVOO and related CVD. 5 Although endovenous and open surgical REVIEW

show abstract

Section: Next Step: Endovenous Interventionmentioning

confidence: 99%

“…36 The reported primary patency ranged from 59% to 94%, and secondary patency ranged from 87% to 100%. 36 Encouraging data are also emerging for the long-term patency rate of endovenous stenting of CVOO. 37 Further, major societies and organizations support its use.…”

Section: Next Step: Endovenous Interventionmentioning

confidence: 99%

Chronic venous outflow obstruction: An important cause of chronic venous disease

Harris

Lim

2021

CCJM

View full text Add to dashboard Cite

show abstract

“…Both arteries and veins are actively stented as a part of different cardiac illnesses treatment. In this study, we have concentrated on vein stenting systems as they are more convenient to use due to the lower pressure in the vessel, around 5 mmHg in large veins in comparison to 100 mmHg in arteries with the similar diameter [30,31,32,33,34].…”

Section: Introductionmentioning

confidence: 99%

Biomechanical behaviour of PEDOT:PSS-based hydrogels as an electrode for stent integrated enzyme biofuel cells

Antipova

Parunova

Vishnevskaya

et al. 2022

Heliyon

View full text Add to dashboard Cite

“…[3][4][5] Subsequent studies have explored dedicated venous stents with reports of good safety, stent patency, and symptomatic improvement, including ulcer healing, reduction of edema, and reduction in rates of subsequent moderate-tosevere post-thrombotic syndrome. [6,7] us, guidelines have recommended endovascular relief of the iliocaval obstruction using stents. [1] e current guidelines recommend a trial of non-invasive therapy before consideration of endovascular treatment.…”

Section: Introductionmentioning

confidence: 99%

Iliocaval stenting for May–Thurner syndrome: Initial experience

Law

Chin

Chu

et al. 2022

JCIS

View full text Add to dashboard Cite

The aim of this report is to describe our experience in endovascular treatment of May–Thurner syndrome. We report three cases of iliocaval stenosis treated endovascularly at our institution. We included three patients age range from 41 to 85 years with two presenting with acute deep vein thrombosis and associated limb swelling and one with chronic lower limb symptoms. We reviewed the technical success, complications, and stent patency on follow-up, latter was monitored be serial imaging. The three cases of iliocaval stenosis were treated with endovascular stenting with follow-up imaging follow-up period ranged from 6 to 13 months (mean 5.6 months) with two out of the three cases maintaining stent patency. One case was complicated by intraprocedural reopening of previously venous bleed. Clinical symptoms resolved with no recurrence in two out of three cases. One case experienced symptomatic in-stent thrombosis following endovascular treatment. Endovascular treatment of iliocaval stenosis appears effective in immediate technical success. Periprocedural attention to anticoagulation and stent position are important in preventing in-stent restenosis.

show abstract

A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents

Cited by 21 publications

References 58 publications

Chronic venous outflow obstruction: An important cause of chronic venous disease

Chronic venous outflow obstruction: An important cause of chronic venous disease

Biomechanical behaviour of PEDOT:PSS-based hydrogels as an electrode for stent integrated enzyme biofuel cells

Iliocaval stenting for May–Thurner syndrome: Initial experience

Contact Info

Product

Resources

About